A detailed history of Centiva Capital, LP transactions in Abbott Laboratories stock. As of the latest transaction made, Centiva Capital, LP holds 18,502 shares of ABT stock, worth $2.13 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
18,502
Previous 21,500 13.94%
Holding current value
$2.13 Million
Previous $2.23 Million 5.6%
% of portfolio
0.04%
Previous 0.04%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $2.41 Million - $2.84 Million
-24,036 Reduced 56.5%
18,502 $2.11 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $3.06 Million - $3.42 Million
30,410 Added 250.74%
42,538 $4.42 Million
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $1.33 Million - $1.47 Million
12,128 New
12,128 $1.38 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $1.37 Million - $1.64 Million
14,341 New
14,341 $1.39 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $1.04 Million - $1.22 Million
-10,972 Reduced 99.66%
37 $4,000
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $289,602 - $335,305
-2,993 Reduced 21.38%
11,009 $1.07 Million
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $607,622 - $734,421
5,953 Added 73.96%
14,002 $1.52 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $1.34 Million - $1.64 Million
-11,773 Reduced 59.39%
8,049 $953,000
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $2.29 Million - $2.8 Million
19,822 New
19,822 $2.79 Million
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $670,285 - $789,022
-6,336 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $1.21 Million - $1.43 Million
-11,120 Reduced 63.7%
6,336 $759,000
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $799,890 - $871,651
7,618 Added 77.43%
17,456 $1.91 Million
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $252,651 - $306,826
-2,757 Reduced 21.89%
9,838 $1.07 Million
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $964,399 - $1.23 Million
12,595 New
12,595 $1.15 Million
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $3.04 Million - $4.45 Million
-48,446 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $1.59 Million - $1.77 Million
20,294 Added 72.09%
48,446 $4.21 Million
Q3 2019

Nov 13, 2019

BUY
$81.84 - $88.74 $2.3 Million - $2.5 Million
28,152 New
28,152 $2.36 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.